These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31076406)

  • 1. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
    Izaguirre-Carbonell J; Christiansen L; Burns R; Schmitz J; Li C; Mokry RL; Bluemn T; Zheng Y; Shen J; Carlson KS; Rao S; Wang D; Zhu N
    Blood Adv; 2019 May; 3(9):1499-1511. PubMed ID: 31076406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JMJD1C-regulated lipid synthesis contributes to the maintenance of
    Qi D; Wang J; Zhao Y; Yang Y; Wang Y; Wang H; Wang L; Wang Z; Xu X; Hu Z
    Leuk Lymphoma; 2022 Sep; 63(9):2149-2160. PubMed ID: 35468015
    [No Abstract]   [Full Text] [Related]  

  • 3. Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells.
    Xu X; Wang L; Hu L; Dirks WG; Zhao Y; Wei Z; Chen D; Li Z; Wang Z; Han Y; Wei L; Drexler HG; Hu Z
    Int J Cancer; 2020 Jan; 146(2):400-412. PubMed ID: 31271662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. shRNA screening identifies JMJD1C as being required for leukemia maintenance.
    Sroczynska P; Cruickshank VA; Bukowski JP; Miyagi S; Bagger FO; Walfridsson J; Schuster MB; Porse B; Helin K
    Blood; 2014 Mar; 123(12):1870-82. PubMed ID: 24501218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
    Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
    Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.
    Chen M; Zhu N; Liu X; Laurent B; Tang Z; Eng R; Shi Y; Armstrong SA; Roeder RG
    Genes Dev; 2015 Oct; 29(20):2123-39. PubMed ID: 26494788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.
    Wong SH; Goode DL; Iwasaki M; Wei MC; Kuo HP; Zhu L; Schneidawind D; Duque-Afonso J; Weng Z; Cleary ML
    Cancer Cell; 2015 Aug; 28(2):198-209. PubMed ID: 26190263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulators of histone demethylase JMJD1C selectively target leukemic stem cells.
    Yang Y; Zhang X; Zhang X; Wang Y; Wang X; Hu L; Zhao Y; Wang H; Wang Z; Wang H; Wang L; Dirks WG; Drexler HG; Xu X; Hu Z
    FEBS Open Bio; 2021 Jan; 11(1):265-277. PubMed ID: 33289299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
    Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.
    Zhu N; Chen M; Eng R; DeJong J; Sinha AU; Rahnamay NF; Koche R; Al-Shahrour F; Minehart JC; Chen CW; Deshpande AJ; Xu H; Chu SH; Ebert BL; Roeder RG; Armstrong SA
    J Clin Invest; 2016 Mar; 126(3):997-1011. PubMed ID: 26878175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative integromics on JMJD1C gene encoding histone demethylase: conserved POU5F1 binding site elucidating mechanism of JMJD1C expression in undifferentiated ES cells and diffuse-type gastric cancer.
    Katoh M; Katoh M
    Int J Oncol; 2007 Jul; 31(1):219-23. PubMed ID: 17549425
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Fu JF; Shih LY; Yen TH
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.
    Yoshihama Y; LaBella KA; Kim E; Bertolet L; Colic M; Li J; Shang X; Wu CJ; Spring DJ; Wang YA; Hart T; DePinho RA
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34475205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets.
    Sharma P; Sattarifard H; Fatemiyan N; Lakowski TM; Davie JR
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis.
    Yin Y; Yang X; Wu S; Ding X; Zhu H; Long X; Wang Y; Zhai S; Chen Y; Che N; Chen J; Wang X
    Nat Immunol; 2022 Sep; 23(9):1342-1354. PubMed ID: 35995859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.